AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,054,000 | +108.4% | 862,809 | +3.3% | 0.00% | +100.0% |
| Q2 2022 | $6,265,000 | -9.8% | 835,386 | +9.4% | 0.00% | 0.0% |
| Q1 2022 | $6,949,000 | +18.1% | 763,732 | -8.9% | 0.00% | 0.0% |
| Q4 2021 | $5,884,000 | -21.0% | 838,313 | +28.3% | 0.00% | 0.0% |
| Q3 2021 | $7,451,000 | -38.5% | 653,610 | -13.6% | 0.00% | -50.0% |
| Q2 2021 | $12,106,000 | -2.8% | 756,214 | +8.5% | 0.00% | 0.0% |
| Q1 2021 | $12,460,000 | +46.5% | 697,287 | +10.8% | 0.00% | +100.0% |
| Q4 2020 | $8,503,000 | +18.6% | 629,391 | +3.3% | 0.00% | 0.0% |
| Q3 2020 | $7,169,000 | -20.6% | 609,109 | -0.4% | 0.00% | -50.0% |
| Q2 2020 | $9,029,000 | +5.0% | 611,772 | -3.9% | 0.00% | 0.0% |
| Q1 2020 | $8,598,000 | -70.0% | 636,914 | -46.2% | 0.00% | -33.3% |
| Q4 2019 | $28,624,000 | +169.0% | 1,184,326 | +113.9% | 0.00% | +50.0% |
| Q3 2019 | $10,641,000 | -32.5% | 553,693 | +3.8% | 0.00% | -50.0% |
| Q2 2019 | $15,766,000 | -30.0% | 533,576 | +12.5% | 0.00% | -33.3% |
| Q1 2019 | $22,536,000 | -28.4% | 474,448 | -45.6% | 0.01% | +20.0% |
| Q4 2018 | $31,470,000 | +23.1% | 871,766 | +109.9% | 0.01% | -28.6% |
| Q3 2018 | $25,564,000 | -5.4% | 415,344 | +3.8% | 0.01% | -12.5% |
| Q2 2018 | $27,031,000 | +47.1% | 400,169 | +18.2% | 0.01% | +33.3% |
| Q1 2018 | $18,373,000 | -4.5% | 338,677 | +5.1% | 0.01% | -14.3% |
| Q4 2017 | $19,244,000 | +28.1% | 322,090 | +4.2% | 0.01% | +16.7% |
| Q3 2017 | $15,028,000 | -2.3% | 309,231 | +5.7% | 0.01% | 0.0% |
| Q2 2017 | $15,379,000 | +29.3% | 292,662 | +11.6% | 0.01% | +20.0% |
| Q1 2017 | $11,891,000 | +23.8% | 262,221 | +3.3% | 0.01% | +25.0% |
| Q4 2016 | $9,608,000 | +20.9% | 253,856 | +20.6% | 0.00% | 0.0% |
| Q3 2016 | $7,945,000 | +143.3% | 210,534 | +13.4% | 0.00% | +100.0% |
| Q2 2016 | $3,266,000 | +66.5% | 185,594 | +15.0% | 0.00% | +100.0% |
| Q1 2016 | $1,961,000 | -49.8% | 161,319 | +0.6% | 0.00% | -50.0% |
| Q4 2015 | $3,905,000 | +48.8% | 160,394 | +8.4% | 0.00% | 0.0% |
| Q3 2015 | $2,624,000 | +57.9% | 147,951 | +57.1% | 0.00% | +100.0% |
| Q2 2015 | $1,662,000 | -36.6% | 94,196 | +12.6% | 0.00% | 0.0% |
| Q1 2015 | $2,622,000 | +9.8% | 83,688 | +2.3% | 0.00% | 0.0% |
| Q4 2014 | $2,388,000 | +51.8% | 81,810 | +7.5% | 0.00% | 0.0% |
| Q3 2014 | $1,573,000 | +24.0% | 76,072 | +48.5% | 0.00% | 0.0% |
| Q2 2014 | $1,269,000 | +21.1% | 51,241 | +3.6% | 0.00% | 0.0% |
| Q1 2014 | $1,048,000 | +56.0% | 49,469 | +32.0% | 0.00% | – |
| Q4 2013 | $672,000 | – | 37,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|